Keybank National Association OH boosted its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 66.4% in the ...

During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on ...

Exosomes Market Exosomes Market is estimated to be valued at USD 222.1 Mn in 2025 and is expected to reach USD 1,284.1 Mn by 2032, exhibiti ...

Discover why Teekay Tankers' strong balance sheet offers stability amid market uncertainty, but long-term profitability may ...

The "Immunotoxins Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment ...

The global stem cell therapy market is poised for remarkable growth, with revenues projected to escalate from USD 394.50 million in 2024 to USD 2,612.92 million by 2033, reflecting a compelling ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Within healthcare, the fund generally avoids speculative biotechs, instead favoring more stable healthcare suppliers such as Bio-Techne. The portfolio's tech holdings skew toward software and ...

MINNEAPOLIS - Bio-Techne Corporation (NASDAQ: TECH), a $10.2 billion market cap company with robust financials and a GOOD health score according to InvestingPro, has started the distribution of its ...